PURDUE PHARMA, LP for PURDUE PHARMA LP
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
HR 3200America's Affordable Health Choices Act of 2009 HR 756National Pain Care Policy Act of 2009 S 660National Pain Care Policy Act of 2009 HR 1260Patent Reform Act of 2009 S 515Patent Reform Act of 2009 S 610Patent Reform Act of 2009 HR 1548Pathway for Biosimilars Act HR 1298Pharmaceutical Market Access and Drug Safety Act of 2009 S 525Pharmaceutical Market Access and Drug Safety Act of 2009 S 301Physician Payments Sunshine Act of 2009 HR 1427Promoting Innovation and Access to Life-Saving Medicine Act S 726Promoting Innovation and Access to Life-Saving Medicine Act HR 1706Protecting Consumer Access to Generic Drugs Act of 2009 S 369Preserve Access to Affordable Generics Act of 2009 HR 1191Safe Drug Disposal Act of 2009 S 1336Safe Drug Disposal Act of 2009 HR 1359Secure and Responsible Drug Disposal Act of 2009 S 1292Secure and Responsible Drug Disposal Act of 2009 Anti- counterfeiting legislation concerning drugs Healthcare Reform Hearings related to prescription drug abuse and prevention Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Health Issues HCR
HR 3200America's Affordable Health Choices Act of 2009 HR 756National Pain Care Policy Act of 2009 S 660National Pain Care Policy Act of 2009 HR 1260Patent Reform Act of 2009 S 515Patent Reform Act of 2009 S 610Patent Reform Act of 2009 HR 1548Pathway for Biosimilars Act HR 1298Pharmaceutical Market Access and Drug Safety Act of 2009 S 525Pharmaceutical Market Access and Drug Safety Act of 2009 S 301Physician Payments Sunshine Act of 2009 HR 1427Promoting Innovation and Access to Life-Saving Medicine Act S 726Promoting Innovation and Access to Life-Saving Medicine Act HR 1706Protecting Consumer Access to Generic Drugs Act of 2009 S 369Preserve Access to Affordable Generics Act of 2009 HR 1191Safe Drug Disposal Act of 2009 S 1336Safe Drug Disposal Act of 2009 HR 1359Secure and Responsible Drug Disposal Act of 2009 S 1292Secure and Responsible Drug Disposal Act of 2009 Anti- counterfeiting legislation concerning drugs Healthcare Reform Hearings related to prescription drug abuse and prevention Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Medicare/Medicaid MMM
HR 3200America's Affordable Health Choices Act of 2009 HR 756National Pain Care Policy Act of 2009 S 660National Pain Care Policy Act of 2009 HR 1260Patent Reform Act of 2009 S 515Patent Reform Act of 2009 S 610Patent Reform Act of 2009 HR 1548Pathway for Biosimilars Act HR 1298Pharmaceutical Market Access and Drug Safety Act of 2009 S 525Pharmaceutical Market Access and Drug Safety Act of 2009 S 301Physician Payments Sunshine Act of 2009 HR 1427Promoting Innovation and Access to Life-Saving Medicine Act S 726Promoting Innovation and Access to Life-Saving Medicine Act HR 1706Protecting Consumer Access to Generic Drugs Act of 2009 S 369Preserve Access to Affordable Generics Act of 2009 HR 1191Safe Drug Disposal Act of 2009 S 1336Safe Drug Disposal Act of 2009 HR 1359Secure and Responsible Drug Disposal Act of 2009 S 1292Secure and Responsible Drug Disposal Act of 2009 Anti- counterfeiting legislation concerning drugs Healthcare Reform Hearings related to prescription drug abuse and prevention Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Alcohol and Drug Abuse ALC
HR 3200America's Affordable Health Choices Act of 2009 HR 756National Pain Care Policy Act of 2009 S 660National Pain Care Policy Act of 2009 HR 1260Patent Reform Act of 2009 S 515Patent Reform Act of 2009 S 610Patent Reform Act of 2009 HR 1548Pathway for Biosimilars Act HR 1298Pharmaceutical Market Access and Drug Safety Act of 2009 S 525Pharmaceutical Market Access and Drug Safety Act of 2009 S 301Physician Payments Sunshine Act of 2009 HR 1427Promoting Innovation and Access to Life-Saving Medicine Act S 726Promoting Innovation and Access to Life-Saving Medicine Act HR 1706Protecting Consumer Access to Generic Drugs Act of 2009 S 369Preserve Access to Affordable Generics Act of 2009 HR 1191Safe Drug Disposal Act of 2009 S 1336Safe Drug Disposal Act of 2009 HR 1359Secure and Responsible Drug Disposal Act of 2009 S 1292Secure and Responsible Drug Disposal Act of 2009 Anti- counterfeiting legislation concerning drugs Healthcare Reform Hearings related to prescription drug abuse and prevention Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BURT E ROSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.